These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1160 related articles for article (PubMed ID: 18566575)
1. Influence of mesenchymal stem cells derived from bone marrow of children with oncohematological diseases on proliferation and self-renewal of hematopoietic progenitor cells in vitro. Isaikina Y; Shman T Exp Oncol; 2008 Jun; 30(2):121-8. PubMed ID: 18566575 [TBL] [Abstract][Full Text] [Related]
2. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro. Isaikina Y; Kustanovich A; Svirnovski A Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907 [TBL] [Abstract][Full Text] [Related]
3. Expansive effects of aorta-gonad-mesonephros-derived stromal cells on hematopoietic stem cells from embryonic stem cells. Fu JR; Liu WL; Zhou YF; Zhou JF; Sun HY; Luo L; Zhang H; Xu HZ Chin Med J (Engl); 2005 Dec; 118(23):1979-86. PubMed ID: 16336834 [TBL] [Abstract][Full Text] [Related]
4. A Stro-1(+) human universal stromal feeder layer to expand/maintain human bone marrow hematopoietic stem/progenitor cells in a serum-free culture system. Gonçalves R; Lobato da Silva C; Cabral JM; Zanjani ED; Almeida-Porada G Exp Hematol; 2006 Oct; 34(10):1353-9. PubMed ID: 16982328 [TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Jang YK; Jung DH; Jung MH; Kim DH; Yoo KH; Sung KW; Koo HH; Oh W; Yang YS; Yang SE Ann Hematol; 2006 Apr; 85(4):212-25. PubMed ID: 16391912 [TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells. Cheng L; Qasba P; Vanguri P; Thiede MA J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234 [TBL] [Abstract][Full Text] [Related]
7. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293 [TBL] [Abstract][Full Text] [Related]
8. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552 [TBL] [Abstract][Full Text] [Related]
9. Quiescent human hematopoietic stem cells in the bone marrow niches organize the hierarchical structure of hematopoiesis. Yahata T; Muguruma Y; Yumino S; Sheng Y; Uno T; Matsuzawa H; Ito M; Kato S; Hotta T; Ando K Stem Cells; 2008 Dec; 26(12):3228-36. PubMed ID: 18787204 [TBL] [Abstract][Full Text] [Related]
10. Biological characterization of CD34+ cells mobilized into peripheral blood. Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890 [TBL] [Abstract][Full Text] [Related]
11. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant. Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells rescue CD34+ cells from radiation-induced apoptosis and sustain hematopoietic reconstitution after coculture and cografting in lethally irradiated baboons: is autologous stem cell therapy in nuclear accident settings hype or reality? Drouet M; Mourcin F; Grenier N; Delaunay C; Mayol JF; Lataillade JJ; Peinnequin A; Hérodin F Bone Marrow Transplant; 2005 Jun; 35(12):1201-9. PubMed ID: 15821761 [TBL] [Abstract][Full Text] [Related]
13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related]
14. Dynamic cell-cell interactions between cord blood haematopoietic progenitors and the cellular niche are essential for the expansion of CD34+, CD34+CD38- and early lymphoid CD7+ cells. da Silva CL; Gonçalves R; dos Santos F; Andrade PZ; Almeida-Porada G; Cabral JM J Tissue Eng Regen Med; 2010 Feb; 4(2):149-58. PubMed ID: 19937912 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750 [TBL] [Abstract][Full Text] [Related]
16. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy. Engelhardt M; Douville J; Behringer D; Jähne A; Smith A; Henschler R; Lange W Bone Marrow Transplant; 2001 Feb; 27(3):249-59. PubMed ID: 11277172 [TBL] [Abstract][Full Text] [Related]
17. Systematic delineation of optimal cytokine concentrations to expand hematopoietic stem/progenitor cells in co-culture with mesenchymal stem cells. Andrade PZ; dos Santos F; Almeida-Porada G; da Silva CL; S Cabral JM Mol Biosyst; 2010 Jul; 6(7):1207-15. PubMed ID: 20424784 [TBL] [Abstract][Full Text] [Related]
18. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis. Choi MR; Kim HY; Park JY; Lee TY; Baik CS; Chai YG; Jung KH; Park KS; Roh W; Kim KS; Kim SH Neurosci Lett; 2010 Mar; 472(2):94-8. PubMed ID: 20117176 [TBL] [Abstract][Full Text] [Related]
19. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449 [TBL] [Abstract][Full Text] [Related]
20. Irradiated Mesenchymal Stem Cells improve the ex vivo expansion of Hematopoietic Progenitors by partly mimicking the bone marrow endosteal environment. Celebi B; Mantovani D; Pineault N J Immunol Methods; 2011 Jul; 370(1-2):93-103. PubMed ID: 21699899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]